You have access
First-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4) Versus 5-FU/LV (de Gramont Regimen)
GIOVANNI SCHINZARI, ERNESTO ROSSI, GIUSEPPINA MAMBELLA, ANTONIA STRIPPOLI, RODOLFO CANGIANO, MASSIMILIANO MUTIGNANI, MICHELE BASSO, ALESSANDRA CASSANO and CARLO BARONE
Anticancer Research September 2017, 37 (9) 5193-5197;